At close: March 31 at 4:00:02 PM EDT ...

甲氨蝶呤（MTX）是一种叶酸类拮抗剂，该药物通过抑制二氢叶酸还原酶（DHFR）来发挥作用，用于治疗类风湿性关节炎。但该药物溶解度差、血浆半衰期短、生物利用度低，口服给药时，胃肠道溶解量有限，限制了药物的吸收量，需要多次用药以达成治疗效果 ...

However, 27 of 188 were still taking their medication between weeks 8 and 10 (after LMP). This number is not high enough to rule out an MTX embryopathy after low dose. The median weekly dose was 10 mg ...

Patients receiving MTX were started at 10 mg/week, which was increased to 20 mg by week 8 if tolerated. In patients for whom a lower dose was indicated/required, an initial dose of 7.5 mg/week was ...

Methotrexate (MTX) is a folate analogue originally synthesised in the 1940s and designed to inhibit dihydrofolate reductase.1 Reduced folate (tetrahydrofolate) is the proximal single carbon donor in ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Comparison of anti-TNFα drugs plus methotrexate (MTX) with MTX alone in patients with insufficient prior responses to MTX showed NNT values of 3 for ACR20, 4 for ACR50 and 8 for ACR70.

OBJECTIVES To determine whether continued methotrexate treatment increases the risk of postoperative infections or of surgical complications in patients with rheumatoid arthritis (RA) within one year ...

It may be concluded that the three marketed anti-TNFα drugs are more effective than the corresponding control treatments (MTX or placebo) in RA patients, with an NNT of 5 for ACR20 and ACR50 and ...

No significant news for MTX in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent ...